Zimbabwe has rejected a major American health deal worth 367 million US dollars (£272m) over five years due to Washington's demand for sensitive data.
The decision came to light following a internal memorandum dated December was disclosed, indicating that Head of State Emmerson Mnangagwa felt the arrangement was "lopsided".
An official spokesperson has since explained that the US was demanding access to genetic material for scientific study and commercial purposes but was not willing to share the resulting advantages from future treatments.
"We will now turn to the challenging and unfortunate task of winding down our support in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy said the United States had provided more than $1.9bn as health assistance to Zimbabwe during the past two decades.
A medical body in Zimbabwe has appealed for continued dialogue to reach a agreement agreeable to both sides so the country's critical HIV treatment initiative can be sustained.
Wider Implications
This rejection follows a comparable situation in neighbouring Kenya, where a court halted a similar health funding agreement following concerns were raised about the safety of Kenyans' health data.
Since returning to office recently, US President Donald Trump has reduced foreign aid and shut down the US Agency for International Development (USAID).
USAID had administered aid for the US government, but Trump argued its expenditure was "wasteful" and his administration was seeking government-to-government agreements to boost transparency and accountability.
Based on reports, Sixteen African countries have so far agreed to these new health pacts, representing over $18.3bn in committed funds.
Details of the Declined Agreement
This assistance for Zimbabwe was intended to funded "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this collaboration might have yielded extraordinary advantages for Zimbabwean communities, especially the 1.2 million men, women and children presently on HIV treatment through American-funded programmes," Tremont added.
However, government spokesperson Nick Mangwana said the arrangement was "asymmetrical".
"Zimbabwe was being asked to share its genetic material and health information over an extended period, without any corresponding assurance of access to any scientific breakthroughs – like new medicines or tests – that might be developed from that shared data," he stated.
"In essence, our country would provide the basic resources for medical research with no certainty that the final treatments would be accessible to our citizens if a future disease outbreak arise."
Sovereignty and Global Health
He also pointed out that the American exit from the global health body and its push of one-on-one health agreements were disrupting systems previously established via the international organization.
Mangwana gave as an example its Pathogen Access and Benefit Sharing system created to manage potential pandemics.
"This framework is designed to guarantee that when a nation contributes its information, the benefits – such as medicines and cures – are distributed fairly, not commercialised solely by those with the resources to develop them."
These objections over the US deal "are not meant as anti-American sentiment," Mangwana stressed.
"We encourage continued dialogue with our US partners on how subsequent collaboration could be designed in a manner that respects the sovereignty and interests of both nations."
Medical Community Response
Medical experts expressed it recognised the government's concerns, but suggested that talks need to persist considering a large portion of the nation's Aids initiatives relied on international support.
"In cases where technical issues arise, such as those involving data governance or implementation frameworks, these can often be addressed through technical clarification and mutually agreed protections," the group said.
The situation underscores the continuing tensions between receiving crucial international aid and safeguarding local interests in an increasingly interconnected world.